Washington,
D.C. 20549
|
Delaware
|
000-50590
|
11-3516358
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
·
|
a Securities
Purchase Agreement dated as of March 20, 2008 with Jungwoo Family Co.,
Ltd., a Korean corporation (“Jungwoo”);
and
|
·
|
a
Securities Purchase Agreement dated as of March 20, 2008 with Super Bio
Co. Ltd., a Korean corporation (“Super
Bio”).
|
·
|
the
sale to Super Bio 357,143 shares of our common stock and a warrant to
purchase 71,429 shares of our common stock for total consideration of
$500,000.20 on March 28,
2008.
|
·
|
the
sale to Jungwoo 285,715 shares of our common stock and a warrant to
purchase 57,143 shares of our common stock for total consideration of
$400,001.00 on March 31, 2008; and
|
(d)
|
Exhibits.
|
Exhibit
Number
|
Description
|
10.1
|
Securities
Purchase Agreement, dated as of March 20, 2008, by and between Rexahn
Pharmaceuticals, Inc. and Jungwoo Family Co., Ltd. (the “Jungwoo
Securities Purchase Agreement”). Filed as Exhibit 10.1 to the Current
Report of Rexahn Pharmaceuticals, Inc. filed on March 26, 2008 and
incorporated herein by reference.
|
10.2
|
Securities
Purchase Agreement, dated as of March 20, 2008, by and between Rexahn
Pharmaceuticals, Inc. and Super Bio Co. Ltd., (the “Super Bio
Securities Purchase Agreement”). Filed as Exhibit 10.2 to the
Current Report of Rexahn Pharmaceuticals, Inc. filed on March 26, 2008 and
incorporated herein by reference.
|
10.3
|
Form
of Warrant issued pursuant to the Jungwoo Securities Purchase Agreement
and the Super Bio Securities Purchase Agreement. Filed as
Exhibit 10.3 to the Current Report of Rexahn Pharmaceuticals, Inc. filed
on March 26, 2008 and incorporated herein by
reference.
|
REXAHN
PHARMACEUTICALS, INC.
|
|||
(Registrant)
|
|||
By:
|
/s/ Chang H.
Ahn
|
||
Chang
H. Ahn
|
|||
Chairman
and Chief Executive Officer
|
Exhibit
Number
|
Description
|
10.1
|
Securities
Purchase Agreement, dated as of March 20, 2008, by and between Rexahn
Pharmaceuticals, Inc. and Jungwoo Family Co., Ltd. (the “Jungwoo
Securities Purchase Agreement”). Filed as Exhibit 10.1 to the Current
Report of Rexahn Pharmaceuticals, Inc. filed on March 26, 2008 and
incorporated herein by reference.
|
10.2
|
Securities
Purchase Agreement, dated as of March 20, 2008, by and between Rexahn
Pharmaceuticals, Inc. and Super Bio Co. Ltd., (the “Super Bio
Securities Purchase Agreement”). Filed as Exhibit 10.2 to the
Current Report of Rexahn Pharmaceuticals, Inc. filed on March 26, 2008 and
incorporated herein by reference.
|
10.3
|
Form
of Warrant issued pursuant to the Jungwoo Securities Purchase Agreement
and the Super Bio Securities Purchase Agreement. Filed as
Exhibit 10.3 to the Current Report of Rexahn Pharmaceuticals, Inc. filed
on March 26, 2008 and incorporated herein by
reference.
|